The US Food and Drug Administration (FDA) approved Abbott’s FreeStyle Libre Pro on September 28 after more than a year of review. The professional continuous glucose monitoring (CGM) system will be made available to US healthcare providers later in Fall 2016.
Abbott’s FreeStyle Libre Pro Professional CGM System Receives FDA Approval
Posted in Glucose & Insulin